Publication:
A Case of Neutrophilic Dermatosis Who Develop Palpable Purpura During the Use of Montelukast

dc.authorwosidKahraman Esen, Hayrünisa/Jjc-1795-2023
dc.authorwosidYildirim Cetin, Gozde/Abf-2868-2021
dc.authorwosidErhan, Çiğdem/Jde-1979-2023
dc.contributor.authorCetin, Gozde Yildirim
dc.contributor.authorSayarlioglu, Hayriye
dc.contributor.authorErhan, Cigdem
dc.contributor.authorKahraman, Hasan
dc.contributor.authorCiralik, Harun
dc.contributor.authorSayarlioglu, Mehmet
dc.date.accessioned2020-06-21T10:44:20Z
dc.date.available2020-06-21T10:44:20Z
dc.date.issued2014
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Cetin, Gozde Yildirim] Sutcu Imam Univ, Fac Med, Dept Rheumatol, Kahramanmaras, Turkey; [Sayarlioglu, Hayriye] Ondokuz Mayis Univ, Fac Med, Dept Nephrol, Samsun, Turkey; [Erhan, Cigdem] Sutcu Imam Univ, Dept Internal Med, Facultry Med, Kahramanmaras, Turkey; [Kahraman, Hasan] Sutcu Imam Univ, Fac Med, Dept Chest Dis, Kahramanmaras, Turkey; [Ciralik, Harun] Sutcu Imam Univ, Fac Med, Dept Pathol, Kahramanmaras, Turkey; [Sayarlioglu, Mehmet] Ondokuz Mayis Univ, Fac Med, Dept Rheumatol, Samsun, Turkeyen_US
dc.description.abstractIn this case report, we present a female patient with neutrophilic dermatosis (ND) occurring as palpable purpura after using montelukast. Neutrophilic dermatoses (NDs) are characterized by skin lesions in which mature neutrophils are predominantly located in the epidermis and dermis in the absence of any infective pathology. Classification of the NDs is based upon the recognition of clinical and pathologic features, as well as the identification of associated diseases, like Sweet's syndrome, pyoderma gangrenosum, generalized pustular psoriasis, and Behcet's disease. Cutaneous findings in NDs are variable and can include vesiculopustules, plaques, nodules, or ulcerations. Drug-induced NDs are not uncommon, but ND with palpable purpura is uncommon. The current patient appeared with a rare presentation as palpable purpura without vasculitis regarding ND. It is important that this is the first case report.en_US
dc.description.woscitationindexEmerging Sources Citation Index
dc.identifier.doi10.5152/eurjrheumatol.2014.140032
dc.identifier.endpage171en_US
dc.identifier.issn2147-9720
dc.identifier.issn2148-4279
dc.identifier.issue4en_US
dc.identifier.pmid27708908
dc.identifier.startpage170en_US
dc.identifier.urihttps://doi.org/10.5152/eurjrheumatol.2014.140032
dc.identifier.volume1en_US
dc.identifier.wosWOS:000218668500012
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofEuropean Journal of Rheumatologyen_US
dc.relation.journalEuropean Journal of Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectNeutrophilic Dermatosisen_US
dc.subjectLeukotriene Receptor Antagonisten_US
dc.subjectMontelukasten_US
dc.titleA Case of Neutrophilic Dermatosis Who Develop Palpable Purpura During the Use of Montelukasten_US
dc.typeArticleen_US
dspace.entity.typePublication

Files